LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 10 of 15: Cell count and normalized growth rate inhibition values within biological replicate 3. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 10 of 15: Cell count and normalized growth rate inhibition values within biological replicate 3. - Dataset (ID:20247)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

|<
<<
Previous
Page 297 of 535
Next
>>
>
7401 to 7425 of 13356 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Replicate	Assay Well	Timepoint	Timepoint Unit	Total Cell Count Before Treatment	Total Cell Count After Treatment	Total Control Cell Count	Relative Cell Count	Normalized Growth Rate Inhibition Value
BT-20	MK2206	0.04	uM	LJP6	3	F06	72	hr	1097	3308	3696	0.8949	0.8772
BT-20	MK2206	0.12	uM	LJP6	1	F05	72	hr	1097	3049	3610	0.8445	0.8126
BT-20	MK2206	0.12	uM	LJP6	2	F05	72	hr	1097	2950	3713	0.7944	0.7546
BT-20	MK2206	0.12	uM	LJP6	3	F05	72	hr	1097	2961	3696	0.8010	0.7622
BT-20	MK2206	0.37	uM	LJP6	1	F04	72	hr	1097	2308	3610	0.6392	0.5415
BT-20	MK2206	0.37	uM	LJP6	2	F04	72	hr	1097	2250	3713	0.6059	0.5042
BT-20	MK2206	0.37	uM	LJP6	3	F04	72	hr	1097	2539	3696	0.6869	0.6141
BT-20	MK2206	1.11	uM	LJP6	1	F03	72	hr	1097	1987	3610	0.5503	0.4128
BT-20	MK2206	1.11	uM	LJP6	2	F03	72	hr	1097	2071	3713	0.5577	0.4350
BT-20	MK2206	1.11	uM	LJP6	3	F03	72	hr	1097	2024	3696	0.5476	0.4182
BT-20	MK2206	3.33	uM	LJP6	1	F02	72	hr	1097	1810	3610	0.5013	0.3381
BT-20	MK2206	3.33	uM	LJP6	2	F02	72	hr	1097	1712	3713	0.4610	0.2878
BT-20	MK2206	3.33	uM	LJP6	3	F02	72	hr	1097	1599	3696	0.4326	0.2398
BT-20	MK2206	10	uM	LJP6	1	F01	72	hr	1097	760	3610	0.2105	-0.1924
BT-20	MK2206	10	uM	LJP6	2	F01	72	hr	1097	708	3713	0.1906	-0.2205
BT-20	MK2206	10	uM	LJP6	3	F01	72	hr	1097	760	3696	0.2056	-0.1891
BT-20	AZD-6482	0.04	uM	LJP5	1	I06	72	hr	1097	3349	3735	0.8966	0.8802
BT-20	AZD-6482	0.04	uM	LJP5	2	I06	72	hr	1097	3757	3877	0.9689	0.9656
BT-20	AZD-6482	0.04	uM	LJP5	3	I06	72	hr	1097	3868	3925	0.9854	0.9840
BT-20	AZD-6482	0.12	uM	LJP5	1	I05	72	hr	1097	3324	3735	0.8899	0.8723
BT-20	AZD-6482	0.12	uM	LJP5	2	I05	72	hr	1097	3732	3877	0.9624	0.9584
BT-20	AZD-6482	0.12	uM	LJP5	3	I05	72	hr	1097	2753	3925	0.7013	0.6491
BT-20	AZD-6482	0.37	uM	LJP5	1	I04	72	hr	1097	2738	3735	0.7330	0.6777
BT-20	AZD-6482	0.37	uM	LJP5	2	I04	72	hr	1097	3276	3877	0.8448	0.8231
BT-20	AZD-6482	0.37	uM	LJP5	3	I04	72	hr	1097	2781	3925	0.7085	0.6582

|<
<<
Previous
Page 297 of 535
Next
>>
>
7401 to 7425 of 13356 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 10 of 15: Cell count and normalized growth rate inhibition values within biological replicate 3. - Dataset (ID:20247)